Re: Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation

European Urology

Volumn 67, Issue 2, 2015, Pages 350-351

  Cha, Eugene K ^a   Bochner, Bernard H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; ESPL1 GENE; EXOME; FGFR3 TACC3 FUSION GENE; FUSION GENE; GENE; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; NOTE; PRIORITY JOURNAL; SISTER CHROMATID; SISTER CHROMATID COHESION; SISTER CHROMATID SEGREGATION; STAG2 GENE; TRANSITIONAL CELL CARCINOMA; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING; BLADDER TUMOR; CHROMOSOME SEGREGATION; GENETICS; SISTER CHROMATID EXCHANGE;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME SEGREGATION; EXOME; HUMANS; SISTER CHROMATID EXCHANGE; URINARY BLADDER NEOPLASMS;

EID: 84920657757     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.11.021     Document Type: Note

References (5)

1. Cancer Genome Atlas Research Network Comprehensive molecular characterization of urothelial bladder carcinoma Nature 507 2014 315 322
2. P.H. Kim, E.K. Cha, and J.P. Sfakianos Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder Eur Urol 67 2015 198 201
3. E.M. Van Allen, K.W. Mouw, and P. Kim Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma Cancer Discov 4 2014 1140 1153
4. G. Iyer, H. Al-Ahmadie, and N. Schultz Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer J Clin Oncol 31 2013 3133 3140
5. G. Iyer, A.J. Hanrahan, and M.I. Milowsky Genome sequencing identifies a basis for everolimus sensitivity Science 338 2012 221